Where is kiadis pharma based? Kiadis Pharma is headquartered in Amsterdam, The Netherlands. Kiadis Pharma was acquired by Sanofi for €308M on Nov 2, 2020.What is keykiadis pharma? Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs.Who are kiadis oncologists? A US citizen, Dr. Sandler is a board certified medical oncologist and has treated many patients with hematologic malignancies, including bone marrow transplant patients. Govert Schouten joined Kiadis in 2020 and is Head of Innovation. Dr.Who is the head of innovation at kiadis? Govert Schouten joined Kiadis in 2020 and is Head of Innovation. Dr. Schouten brings nearly 25 years of experience in developing and implementing strategies to build businesses and create value.
Research Focus: Cancer Immunotherapeutics & HSCT. Kiadis Pharma is focused on cell-based immunotherapy products for the treatment of life threatening diseases. Kiadis is focused on developing new cancer immunotherapeutics as well as novel adjunctive treatments for patients undergoing hematopoietic stem cell transplants. Our research focus.